查看購物車
  • English
封面
市場調查報告書
商品編碼
1912604

自動化核酸合成市場：依技術、通量、產品類型、應用和最終用戶分類－2026-2032年全球預測

Automatic Nucleic Acid Synthesizer Market by Technology, Throughput, Product Type, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，自動化核酸合成儀市值將達到 4.6527 億美元，到 2026 年將成長至 5.0932 億美元，到 2032 年將達到 8.8027 億美元，年複合成長率為 9.53%。

關鍵市場統計數據
基準年 2025 4.6527億美元
預計年份：2026年 5.0932億美元
預測年份 2032 8.8027億美元
複合年成長率 (%) 9.53%

本書權威地介紹了自動化核酸合成技術及其在現代研究、臨床診斷和治療開發中的重要角色。

自動化核酸合成儀已從一種罕見的專用桌上型儀器發展成為現代生命科學工作流程中不可或缺的一部分。這些平台能夠自動產生寡核苷酸，簡化引子、探針、小干擾RNA和合成基因的生成流程，而這些正是研究、診斷和治療開發的基礎。隨著分子生物學技術在學術界、臨床和工業界的日益普及，按需可靠地產生客製化序列的能力已成為追求敏捷性和可重複性的機構的核心競爭力。

小型化、模組化自動化和整合軟體的融合如何重塑核酸合成領域的買方期望、供應商策略和營運模式

隨著技術、營運和市場力量的融合，自動化核酸合成領域正經歷著快速而變革性的轉變。小型化和微流體控技術的進步使得更緊湊的合成裝置成為可能，並促進了現場合成的普及；而平行化和機器人技術則擴展了高通量發現工作流程的容量。這些技術進步與固相化學和純化策略的改進相輔相成，降低了錯誤率，並拓寬了使用者可用的化學方法選擇。

評估2025年關稅趨勢和貿易政策轉變如何重塑核酸合成設備生態系統的供應鏈、採購時機和製造策略

2025年關稅政策的變化為核酸合成設備價值鏈上的相關人員帶來了新的挑戰。影響進口零件、儀器組件和特殊耗材的關稅調整，使得供應鏈韌性問題日益凸顯，迫使製造商和採購商重新評估籌資策略和營運緩衝。為此，一些製造商正加強推進關鍵供應鏈的在地化，在多個地區尋找替代供應商，並提高庫存透明度，以緩解潛在的前置作業時間波動。

詳細的細分分析揭示了技術架構、最終用戶優先順序、應用需求、吞吐量需求和產品類型如何驅動購買決策和產品藍圖。

對市場區隔的詳細分析揭示了技術和使用者主導的顯著動態，這些動態塑造了產品設計、服務模式和市場推廣策略。基於技術，平台可分為基於色譜柱的架構和基於薄膜的架構，兩者在合成精度、週期時間和放大難度方面各有優劣。基於色譜柱的系統通常著重於成熟的化學方法和批次一致性，而基於薄膜的設計則可在特定應用中提供通量和並行性方面的優勢。

對美洲、歐洲、中東和非洲以及亞太市場進行全面的區域分析，包括推動市場接受度的因素、監管方面的細微差別以及影響市場需求的商業策略。

區域趨勢對核酸合成產業的技術應用、監管要求和商業策略有顯著影響。在美洲，學術研究中心、生物技術叢集以及完善的合約研究生態系統支撐了對柔軟性的桌上型和可擴展的機器人解決方案的需求。該地區的監管環境和報銷機制進一步推動了對診斷和治療研發的投資，刺激了對檢驗的工作流程和供應商協助實施服務的需求。

競爭情報和策略定位洞察，揭示產品生態系統、夥伴關係和售後服務如何為設備製造商和整合商打造制勝之道。

自動化核酸合成領域的競爭動態體現了成熟儀器產品組合與敏捷的新興企業之間的平衡，後者專注於透過軟體、耗材和服務實現差異化。領先供應商憑藉其整合的耗材生態系統、檢驗的通訊協定以及全球支持，在法規環境下降低了准入門檻，從而保持了競爭優勢。同時，新興企業專注於微流體技術、新型固體相載體以及以用戶為中心的軟體等細分創新，以加快特定應用的實驗結果獲取速度。

為製造商、供應商和機構買家提供切實可行的策略建議，以增強其韌性，實現服務差異化，並推動不同終端用戶採用其產品和服務。

產業領導者應採取務實且多管齊下的策略，在加快目標終端用戶採用新方案的同時，降低供應鏈波動帶來的風險。首先，應優先考慮模組化產品架構和零件標準化，使組裝和服務營運能夠在不同生產基地之間靈活轉移，無需進行大量的重新認證。這種「面向韌性的設計」方法能夠縮短在地化進程，並降低貿易政策變化對營運的影響。

我們透明、以證據為基礎的調查方法結合了專家訪談、技術檢驗和供應鏈映射，為策略規劃者和採購主管提供可操作的見解。

本分析所依據的研究採用了一種混合調查方法，結合了專家訪談、結構化的二手資料審查和跨職能檢驗。主要研究包括對設備工程師、實驗室主任、採購主管和服務經理進行有針對性的訪談，以收集有關營運挑戰、實施標準和供應商選擇趨勢的第一手資料。隨後，將這些定性見解與產品文件、專利申請、技術白皮書和監管指南進行交叉比對，以檢驗技術聲明並識別新興的工程趨勢。

本文探討了技術創新、服務經濟和政策趨勢如何共同決定自動化核酸合成系統的成功應用。

總而言之，自動化核酸合成儀在現代生命科學工具包中扮演核心角色，該領域正處於技術創新、服務經濟和政策主導的供應鏈趨勢交匯點，並迅速發展。平台架構的技術進步，以及對研究、診斷和治療應用日益成長的需求，正在推動產品在通量、整合能力和生命週期支援等方面實現差異化。同時，近期貿易和政策趨勢凸顯了供應鏈韌性和模組化設計對於維持實驗室運作連續性的重要性。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 自動化核酸合成儀市場：依技術分類

  • 基於列
  • 基於膜的

9. 依處理能力分類的自動化核酸合成儀市場

  • 高通量
  • 低吞吐量

第10章 依產品類型分類的自動化核酸合成儀市場

  • 桌上型合成設備
  • 機器人合成設備

第11章 自動核酸合成儀市場：依應用分類

  • 反義寡核苷酸合成
  • 基因合成
  • PCR引子合成
  • siRNA合成

第12章 依最終用戶分類的自動化核酸合成儀市場

  • 學術研究機構
  • CRO（受託研究機構）
  • 診斷檢查室
  • 製藥和生物技術

第13章 各地區自動化核酸合成儀市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 自動化核酸合成儀市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國自動化核酸合成儀市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國自動化核酸合成儀市場

第17章 中國全自動核酸合成儀市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Agilent Technologies, Inc.
  • BioAutomation, Inc.
  • Bioneer Corporation
  • BIOSSET Ltd.
  • Biotage AB
  • CEM Corporation
  • Intavis AG
  • K&A Laborgerate GmbH
  • Labmate Scientific LLC
  • MABEAL GmbH
  • Thermo Fisher Scientific Inc.
Product Code: MRR-AE420CB13A55

The Automatic Nucleic Acid Synthesizer Market was valued at USD 465.27 million in 2025 and is projected to grow to USD 509.32 million in 2026, with a CAGR of 9.53%, reaching USD 880.27 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 465.27 million
Estimated Year [2026] USD 509.32 million
Forecast Year [2032] USD 880.27 million
CAGR (%) 9.53%

An authoritative introduction to automated nucleic acid synthesis technologies and their pivotal role in modern research, clinical diagnostics, and therapeutic development

Automatic nucleic acid synthesizers have transitioned from specialized benchtop curiosities into indispensable instruments for modern life sciences workflows. These platforms automate oligonucleotide production, streamlining the generation of primers, probes, small interfering RNAs, and synthetic genes that underpin research, diagnostics, and therapeutic development. As molecular biology techniques have proliferated across academic, clinical, and industrial settings, the ability to produce custom sequences reliably and on demand has become a core capability for organizations seeking agility and reproducibility.

The current generation of synthesizers emphasizes efficiency, error reduction, and integration with downstream processes. Innovations in reagent chemistry, solid supports, and automation control have reduced hands-on time and improved synthesis fidelity. Consequently, laboratories increasingly evaluate synthesizer performance not only by throughput but by the total workflow impact, including consumable logistics, instrument footprint, and compatibility with automation ecosystems. This evolution has driven manufacturers to differentiate across technology architectures, throughput capabilities, and product typologies to meet the divergent needs of research labs, contract service providers, diagnostics facilities, and pharmaceutical R&D groups.

Moving forward, the interplay between instrument design, consumable ecosystems, and digital controls will determine which solutions best support reproducible, scalable nucleic acid production. Decision-makers must weigh operational priorities, regulatory expectations, and integration requirements when specifying platforms to ensure that investments yield durable productivity gains across projects and teams.

How convergence of miniaturization, modular automation and integrated software is reshaping buyer expectations, supplier strategies and operational models in nucleic acid synthesis

The landscape for automatic nucleic acid synthesizers is undergoing rapid, transformative shifts driven by converging technological, operational, and market forces. Advances in miniaturization and microfluidic control have enabled more compact formats that democratize on-site synthesis, while parallelization and robotics expand capacity for high-throughput discovery workflows. These engineering advances are complemented by improvements in solid-phase chemistries and purification strategies that reduce error rates and broaden the menu of chemistries available to users.

Concurrently, demand patterns are changing: academic and research institutes continue to value flexibility and cost-effectiveness, contract research organizations prioritize scalable throughput and regulatory compliance, diagnostics laboratories require validated SOPs and traceability, and pharmaceutical and biotechnology firms focus on integration with automated discovery pipelines and GMP-compatible workflows. These shifts incentivize manufacturers to offer modular instrument architectures that can evolve with user requirements, supporting both low-throughput bench setups and high-throughput automated lines. At the same time, software capabilities that enable remote monitoring, predictive maintenance, and process analytics are becoming central differentiators that improve uptime and reduce total cost of ownership.

Importantly, the industry is responding to broader ecosystem trends such as the drive toward decentralized manufacturing, the rise of nucleic acid therapeutics, and the adoption of digital laboratory infrastructure. Strategic partnerships between instrument makers, consumable suppliers, and laboratory automation integrators are increasing, fostering bundled solutions that accelerate adoption. Overall, these transformative shifts are redefining buyer expectations, moving the market toward integrated, service-oriented offerings that deliver reproducible output across diverse end users and applications.

Assessment of how recent tariff developments and trade policy shifts in 2025 are reshaping supply chains, procurement timing and manufacturing strategies across nucleic acid synthesizer ecosystems

Policy changes in 2025 relating to tariff regimes have introduced a new layer of complexity for stakeholders in the nucleic acid synthesizer value chain. Tariff adjustments affecting imported components, instrument assemblies and specialized consumables have amplified the attention on supply chain resilience, compelling manufacturers and buyers alike to re-evaluate sourcing strategies and operational buffers. In response, several manufacturers have intensified efforts to localize key supply chains, qualify alternative suppliers across multiple geographies, and increase inventory transparency to mitigate potential lead-time variability.

These tariff-driven dynamics have also influenced procurement timing and contract structures. Organizations with ongoing capital expenditure plans are rethinking fiscal phasing to avoid exposure to incremental duties, while service providers are negotiating longer-term supply agreements to stabilize pricing and availability for clients. For laboratories and contract providers that depend on consumables sourced internationally, the increased import costs have heightened the importance of supplier consolidation and vendor-managed inventory arrangements that smooth operational continuity.

Regulatory and trade policy unpredictability has further incentivized product modularization and component standardization. When component interfaces are standardized, manufacturers can more readily shift assembly or component sourcing to alternate regions without extensive requalification. As a result, design-for-manufacturability and supply-chain-aware engineering have become central to commercial strategy. In the near term, stakeholders should expect sustained attention on tariff risk in procurement evaluations and a continued trend toward geographic diversification of suppliers and assembly operations to reduce exposure to policy fluctuations.

Deep segmentation analysis revealing how technology architecture, end user priorities, application requirements, throughput demands and product typology drive purchasing decisions and product roadmaps

A granular understanding of market segmentation reveals distinct technology and user-driven dynamics that shape product design, service models, and go-to-market tactics. Based on technology, platforms fall into column based architectures and membrane based approaches, each presenting unique trade-offs between synthesis fidelity, cycle time, and ease of scale-up. Column based systems typically emphasize established chemistries and batch consistency, while membrane based designs can provide advantages in throughput and parallelization for certain applications.

Based on end user, the buyer landscape comprises academic and research institutes, contract research organizations, diagnostics laboratories, and pharma and biotech entities; within pharma and biotech, requirements diverge between biotechnology firms focused on rapid iteration and large pharmaceutical companies prioritizing regulatory pathways and scale. These end-user distinctions drive different purchasing rationales: smaller research labs value compact benchtop instruments and ease of use, service providers and CROs emphasize throughput and process robustness, diagnostics facilities require validated workflows and traceability, and larger biopharma organizations seek platforms that can integrate into automated discovery and production pipelines.

Based on application, instruments are applied across antisense oligonucleotide synthesis, gene synthesis, PCR primer synthesis, and siRNA synthesis, each application imposing specific purity, error tolerance, and throughput expectations that influence instrument architecture and consumable design. Based on throughput, solutions are configured for high throughput or low throughput use cases, with high-throughput deployments prioritizing parallelization, automation integration, and consumable logistics, whereas low-throughput installations prioritize flexibility, cost per run, and footprint. Finally, based on product type, offerings range from bench top synthesizers to robotic synthesizers; bench top units support decentralized, on-demand synthesis with rapid turnaround, while robotic systems enable centralized, large-scale operations with automation-driven consistency. These segmentation lenses collectively inform product roadmaps and commercialization strategies, enabling firms to tailor value propositions to discrete user needs and operational constraints.

A comprehensive regional breakdown of adoption drivers, regulatory nuances and commercial strategies shaping demand across the Americas, Europe, Middle East & Africa and Asia-Pacific markets

Regional dynamics exert a significant influence on technology adoption, regulatory expectations, and commercial strategies across the nucleic acid synthesizer landscape. In the Americas, strong presence of academic research hubs, biotechnology clusters and an extensive contract research ecosystem supports demand for both benchtop flexibility and scalable robotic solutions. The regulatory environment and reimbursement pathways in this region further encourage investments in diagnostics and therapeutic discovery, stimulating demand for validated workflows and vendor-supported implementation services.

In Europe, Middle East & Africa, fragmentation of regulatory regimes and diverse laboratory infrastructure create mixed adoption patterns; early-adopter urban centers and national genomics initiatives drive demand for advanced automation, while cost-sensitive markets prioritize compact, lower-footprint equipment and consumable affordability. This regional complexity favors manufacturers that can offer modular solutions and localized support networks to address varying serviceability and validation needs.

Across Asia-Pacific, rapid expansion of life sciences investment, increasing domestic manufacturing capabilities, and government-led biotechnology initiatives are accelerating uptake of both high-throughput automated lines and versatile bench top systems. Regional supply chain development and component manufacturing hubs also create strategic opportunities for firms that pursue localization strategies. Taken together, regional differences in funding mechanisms, regulatory expectations, and industrial policy shape product positioning, after-sales support models, and partnership strategies for vendors operating across these territories.

Competitive intelligence and strategic positioning insights revealing how product ecosystems, partnerships and aftermarket services define winning plays for instrument manufacturers and integrators

Competitive dynamics in the automatic nucleic acid synthesizer arena reflect a balance between established instrument portfolios and agile entrants that emphasize software, consumables, and service differentiation. Leading vendors maintain competitive moats through integrated consumable ecosystems, validated protocols, and global support footprints that reduce adoption friction for regulated environments. Meanwhile, emerging firms focus on niche technical innovations such as microfluidics, novel solid supports, or user-centric software that accelerates time-to-result for specific applications.

Strategic behavior increasingly centers on ecosystem plays: manufacturers align with consumable suppliers, software providers, and automation integrators to deliver turnkey solutions that minimize integration risk for customers. Partnerships and co-development agreements are common, enabling cross-validation of reagents and instruments to meet diagnostic and therapeutic quality requirements. At the same time, companies are investing in aftermarket services such as remote diagnostics, preventive maintenance contracts, and consumable subscription models that generate recurring revenue and deepen customer relationships.

Intellectual property portfolios and regulatory know-how are key differentiators for firms targeting pharmaceutical and diagnostics customers; the ability to support validation, traceability, and documentation for regulated workflows enhances competitiveness with large institutional buyers. Ultimately, success depends on combining robust technical performance with scalable service delivery and a clear value proposition for diverse end users, from single-lab adopters to centralized contract manufacturing facilities.

Actionable strategic recommendations for manufacturers, suppliers and institutional buyers to enhance resilience, differentiate service offerings and accelerate adoption across diverse end users

Industry leaders should adopt pragmatic, multi-pronged strategies that reduce exposure to supply-chain volatility while accelerating adoption among target end users. First, prioritize modular product architectures and component standardization so that assembly and service operations can pivot across production sites without extensive requalification. This design-for-resilience approach shortens the path to localization and reduces the operational impact of trade policy shifts.

Second, invest in integrated service offerings that bundle instrument hardware with validated consumables, remote monitoring, and training programs. By shifting value toward recurring service relationships, vendors can stabilize revenue streams and deliver measurable uptime improvements for customers. Third, develop targeted go-to-market approaches for distinct end users: emphasize ease of use and cost efficiency for academic labs, turnkey automation and compliance support for diagnostics laboratories, and scalable, validated platforms for pharmaceutical and biotech clients. Fourth, accelerate digital enablement by embedding telemetry and analytics capabilities that support predictive maintenance and process optimization; these capabilities reduce total cost of ownership and create differentiation in procurement evaluations.

Finally, cultivate strategic partnerships across reagent suppliers, automation integrators, and local service providers to expand addressable markets and shorten customer implementation timelines. These collaborative arrangements facilitate bundled demonstrations, joint validation exercises, and co-marketing that increase credibility with regulated buyers. Taken together, these recommendations equip industry leaders to navigate near-term policy headwinds while building durable competitive advantage in a rapidly evolving landscape.

Transparent, evidence-based research methodology combining expert interviews, technical validation and supply chain mapping to produce practical insights for strategists and procurement leaders

The research underpinning this analysis employed a hybrid methodology that combined primary expert engagements with structured secondary review and cross-functional validation. Primary research included targeted interviews with instrument engineers, laboratory directors, procurement leads, and service managers to capture firsthand perspectives on operational pain points, adoption criteria, and supplier selection dynamics. These qualitative inputs were triangulated with product documentation, patent filings, technical whitepapers, and regulatory guidance to validate technical claims and identify emerging engineering trends.

Secondary research encompassed a systematic review of peer-reviewed literature, conference proceedings, and public filings to chart recent technological advances in reagent chemistry, solid supports, and automation architectures. Supply chain mapping exercises identified critical component categories and common sourcing geographies, while case study analysis of laboratory deployments provided insight into implementation timelines and service model effectiveness. Throughout the process, iterative validation sessions with industry experts refined assumptions and ensured that conclusions were grounded in practical operational realities.

The methodology prioritized transparency and reproducibility: source material selection focused on primary technical references and domain experts, while analytical frameworks emphasized comparative techno-commercial assessment rather than numeric market sizing. This approach produces insights that are actionable for product strategy, procurement planning, and operational risk management.

Concluding synthesis on how technological innovation, service economics and policy dynamics collectively determine success in automated nucleic acid synthesis deployments

In summary, automatic nucleic acid synthesizers occupy a central role in the modern life sciences toolkit, and the sector is evolving rapidly at the intersection of engineering innovation, service economics, and policy-driven supply chain dynamics. Technological advances in platform architectures, coupled with growing demand across research, diagnostic and therapeutic applications, are driving product differentiation along axes of throughput, integration capability, and lifecycle support. At the same time, recent trade and policy developments have underscored the need for supply chain resilience and modular design to sustain uninterrupted laboratory operations.

For stakeholders across the value chain, the path forward requires balancing near-term risk mitigation with long-term strategic investments. Manufacturers should prioritize modularity and service-led offerings to capture recurring value, while buyers should emphasize supplier qualification, validation support, and integration compatibility when selecting platforms. Partnerships that align instrument makers with consumable vendors and automation integrators will accelerate deployment and reduce adoption friction for regulated environments. Ultimately, organizations that combine technical rigor with operational foresight will be best positioned to convert instrument capability into reproducible, cost-effective outcomes for research and clinical workflows.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Automatic Nucleic Acid Synthesizer Market, by Technology

  • 8.1. Column Based
  • 8.2. Membrane Based

9. Automatic Nucleic Acid Synthesizer Market, by Throughput

  • 9.1. High Throughput
  • 9.2. Low Throughput

10. Automatic Nucleic Acid Synthesizer Market, by Product Type

  • 10.1. Bench Top Synthesizer
  • 10.2. Robotic Synthesizer

11. Automatic Nucleic Acid Synthesizer Market, by Application

  • 11.1. Antisense Oligonucleotide Synthesis
  • 11.2. Gene Synthesis
  • 11.3. PCR Primer Synthesis
  • 11.4. siRNA Synthesis

12. Automatic Nucleic Acid Synthesizer Market, by End User

  • 12.1. Academic And Research Institutes
  • 12.2. Contract Research Organizations
  • 12.3. Diagnostics Laboratories
  • 12.4. Pharma And Biotech

13. Automatic Nucleic Acid Synthesizer Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Automatic Nucleic Acid Synthesizer Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Automatic Nucleic Acid Synthesizer Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Automatic Nucleic Acid Synthesizer Market

17. China Automatic Nucleic Acid Synthesizer Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Agilent Technologies, Inc.
  • 18.6. BioAutomation, Inc.
  • 18.7. Bioneer Corporation
  • 18.8. BIOSSET Ltd.
  • 18.9. Biotage AB
  • 18.10. CEM Corporation
  • 18.11. Intavis AG
  • 18.12. K&A Laborgerate GmbH
  • 18.13. Labmate Scientific LLC
  • 18.14. MABEAL GmbH
  • 18.15. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY THROUGHPUT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY COLUMN BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY COLUMN BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY COLUMN BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY MEMBRANE BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY MEMBRANE BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY MEMBRANE BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY HIGH THROUGHPUT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY HIGH THROUGHPUT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY HIGH THROUGHPUT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY LOW THROUGHPUT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY LOW THROUGHPUT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY LOW THROUGHPUT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY BENCH TOP SYNTHESIZER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY BENCH TOP SYNTHESIZER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY BENCH TOP SYNTHESIZER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY ROBOTIC SYNTHESIZER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY ROBOTIC SYNTHESIZER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY ROBOTIC SYNTHESIZER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY ANTISENSE OLIGONUCLEOTIDE SYNTHESIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY ANTISENSE OLIGONUCLEOTIDE SYNTHESIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY ANTISENSE OLIGONUCLEOTIDE SYNTHESIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY GENE SYNTHESIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY GENE SYNTHESIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY GENE SYNTHESIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY PCR PRIMER SYNTHESIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY PCR PRIMER SYNTHESIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY PCR PRIMER SYNTHESIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY SIRNA SYNTHESIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY SIRNA SYNTHESIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY SIRNA SYNTHESIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY DIAGNOSTICS LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY DIAGNOSTICS LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY DIAGNOSTICS LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY PHARMA AND BIOTECH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY PHARMA AND BIOTECH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY PHARMA AND BIOTECH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. AMERICAS AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 51. AMERICAS AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 52. AMERICAS AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 53. AMERICAS AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 54. AMERICAS AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 55. AMERICAS AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 56. NORTH AMERICA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. NORTH AMERICA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 58. NORTH AMERICA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 59. NORTH AMERICA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 60. NORTH AMERICA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 61. NORTH AMERICA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 62. LATIN AMERICA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. LATIN AMERICA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 64. LATIN AMERICA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 65. LATIN AMERICA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 66. LATIN AMERICA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 67. LATIN AMERICA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 68. EUROPE, MIDDLE EAST & AFRICA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 69. EUROPE, MIDDLE EAST & AFRICA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 70. EUROPE, MIDDLE EAST & AFRICA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 71. EUROPE, MIDDLE EAST & AFRICA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 72. EUROPE, MIDDLE EAST & AFRICA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 73. EUROPE, MIDDLE EAST & AFRICA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 74. EUROPE AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. EUROPE AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 76. EUROPE AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 77. EUROPE AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 78. EUROPE AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 79. EUROPE AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 80. MIDDLE EAST AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. MIDDLE EAST AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 82. MIDDLE EAST AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 83. MIDDLE EAST AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 84. MIDDLE EAST AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 85. MIDDLE EAST AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 86. AFRICA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. AFRICA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 88. AFRICA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 89. AFRICA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 90. AFRICA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 91. AFRICA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. ASEAN AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. ASEAN AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 101. ASEAN AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 102. ASEAN AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. ASEAN AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 104. ASEAN AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 105. GCC AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GCC AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 107. GCC AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 108. GCC AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. GCC AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 110. GCC AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPEAN UNION AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPEAN UNION AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPEAN UNION AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPEAN UNION AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPEAN UNION AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPEAN UNION AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 117. BRICS AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. BRICS AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 119. BRICS AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 120. BRICS AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. BRICS AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 122. BRICS AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 123. G7 AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. G7 AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 125. G7 AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 126. G7 AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. G7 AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 128. G7 AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 129. NATO AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. NATO AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 131. NATO AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 132. NATO AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. NATO AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 134. NATO AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. UNITED STATES AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 137. UNITED STATES AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 138. UNITED STATES AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 139. UNITED STATES AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. UNITED STATES AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 141. UNITED STATES AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 142. CHINA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 143. CHINA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 144. CHINA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 145. CHINA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. CHINA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 147. CHINA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)